TriSalus Life Sciences, Inc.
TLSI
$6.45
-$0.55-7.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.69M | 26.49M | 13.00M | 8.53M | 11.29M |
| Total Receivables | 5.00M | 5.57M | 5.45M | 5.09M | 4.91M |
| Inventory | 3.28M | 3.81M | 4.16M | 4.05M | 4.00M |
| Prepaid Expenses | 2.37M | 2.22M | 2.48M | 3.01M | 3.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 33.33M | 38.08M | 25.10M | 20.67M | 23.81M |
|
|
|||||
| Total Current Assets | 33.33M | 38.08M | 25.10M | 20.67M | 23.81M |
| Net Property, Plant & Equipment | 2.72M | 2.81M | 3.11M | 2.88M | 3.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 419.00K | 419.00K | 424.00K | 423.00K | 424.00K |
| Total Assets | 36.46M | 41.32M | 28.63M | 23.97M | 27.48M |
|
|
|||||
| Total Accounts Payable | 3.78M | 1.90M | 2.81M | 2.27M | 1.45M |
| Total Accrued Expenses | 6.77M | 7.02M | 8.31M | 7.32M | 7.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 129.00K | 123.00K | 118.00K | 216.00K | 266.00K |
| Total Finance Division Other Current Liabilities | 224.00K | 279.00K | 515.00K | 417.00K | 363.00K |
| Total Other Current Liabilities | 224.00K | 279.00K | 515.00K | 417.00K | 363.00K |
| Total Current Liabilities | 10.91M | 9.32M | 11.75M | 10.23M | 9.92M |
|
|
|||||
| Total Current Liabilities | 10.91M | 9.32M | 11.75M | 10.23M | 9.92M |
| Long-Term Debt | 32.76M | 32.27M | 31.70M | 22.08M | 21.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.23M | 1.27M | 1.30M | 1.33M | 1.51M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.28M | 17.88M | 18.24M | 16.22M | 14.81M |
| Total Liabilities | 63.19M | 60.74M | 63.00M | 49.87M | 47.91M |
|
|
|||||
| Common Stock & APIC | 294.25M | 278.79M | 255.55M | 253.66M | 249.01M |
| Retained Earnings | -320.97M | -298.21M | -289.92M | -279.55M | -269.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.73M | -19.42M | -34.37M | -25.89M | -20.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.73M | -19.42M | -34.37M | -25.89M | -20.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.73M | -19.42M | -34.37M | -25.89M | -20.43M |
|
|
|||||